Joe McCann, Point Biopharma CEO (via Point)
Point unveils new Indy site to shore up supply chain in fight against prostate cancer
With a new manufacturing facility and a candidate for prostate cancer in clinical trials, Point Biopharma is moving fast to bring its radioligand operations online …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.